BEVERLY HILLS, Calif.,
April 8, 2014 /PRNewswire/
-- Life Stem Genetics, Inc. (LIFS), an emerging company in the
advancement of adult stem cell therapies, today announced the
appointments of Dr. Roberto Fernandez
Vina, Dr. Ranbir Singh Gill,
and Dr. Praveen Gill to its Medical
Advisory Board.
Dr. Roberto Fernandez
Vina
Born and educated in Argentina,
Dr. Roberto Fernandez Vina, MD
Cardiology, is a pioneer in the development of multiple adult stem
cell therapies, protocols, and medical devices. Dr. Vina has
performed many diabetes stem cell treatments around the world. In
2003, he organized a ground-breaking trial for the implantation of
stem cells into recent heart attack victims receiving bypass
operations. In 2005, he became the first doctor to prove in a
clinical trial that adult stem cells significantly improved the
lives of type-2 diabetes patients. During 2006 to 2007, he
pioneered stem cell treatments for emphysema and Chronic
Obstructive Pulmonary Disorder (COPD). Dr. Vina is also an
Argentine Interventional Cardiologist Professor and serves as Chief
of Endovascular Therapeutics Service at the Benetti Foundation,
Argentina.
Dr. Ranbir Singh Gill
Dr. Ranbir Singh Gill, MD
Internal Medicine, received his medical degree from the prestigious
Medical College of Amritsar, India, in 1985 and completed his MD in
Internal Medicine in 1992. Specializing in cardiology, he completed
a Fellowship in Cardiology from Escorts Heart Institute &
Research Centre in New Delhi,
India, under the guidance of cardiac surgeon Dr.
N. Trehan. In pursuit of his
passion, Dr. Gill regularly attends national and international
cardiology conferences and has traveled to remote areas of
India where he performed
echocardiography for the detection and prevalence of heart disease
in these less densely populated areas. He has a keen interest in
the role genetics play in the prevention of cardiomyopathy. He is
married to Dr. Praveen Gill who also
serves on Life Stem's Medical Advisory Board.
Dr. Praveen Gill
Dr. Praveen Gill, MD Pediatrics,
hails from India and was clinical
attache to the Post Graduate Institute and panel member of the
Fortis Group of Hospitals, both in India. Dr. Gill served as assistant professor
at the SGRD Medical Institute & Research Centre in Amritsar,
India, and is a known figure in
the field of pediatrics. Specializing in neonatology, she has
performed genetic screening and carrier detection and believes that
pediatricians and geneticists can work in unison to strengthen the
clinical applications of genetics to pediatric endocrinology. Her
husband is Dr. Ranbir Singh Gill who
also serves on Life Stem's Medical Advisory Board.
About Life Stem Genetics
Life Stem Genetics, symbol: LIFS, is a fully reporting, audited
public company. LIFS is a progressive healthcare company focused on
Adult Stem Cell ("ASC") healing therapies and stem cell related
products. Stem cells have been utilized in the successful treatment
of a variety of ailments. Today, advanced ASC therapies are being
offered to patients as an efficient and painless alternative
treatment for a wide range of ailments including, but not limited
to, orthopedic injuries, neurological disorders such as Parkinson's
and Alzheimer's, cancer, arthritis, diabetes, cardiology, multiple
sclerosis, as well as age management.
Find the full disclosure and disclaimer at the following
links:
ABOUT LIFESTEM GENETICS (direct
link: http://www.lifestemgenetics.com/aboutus.php)
DISCLAIMER (direct
link: http://www.lifestemgenetics.com/disclaimer.php)
CONTACT: Life Stem Genetics, Shareholder Relations, Office
+1-310-279-5234, info@LifeStemGenetics.com,
http://www.LifeStemGenetics.com
SOURCE Life Stem Genetics